Open an account

Quantum-Si

QSI · NASDAQ

$1.16+$0.07 (+6.42%)TodayMarket closed ·
Prev close $1.09

About QSI

Quantum-Si, Inc. is a life sciences company focused on revolutionizing the growing field of proteomics. The company is headquartered in Branford, Connecticut and currently employs 145 full-time employees. The company went IPO on 2020-09-04. The firm has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. The company has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.

Employees
145
Headquarters
Branford, Connecticut
Listed
Sep 4, 2020
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
quantum-si.com

QSI key statistics

Market cap
253.91M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
11.37M
Volume
6.18M
Open price
$1.06
High today
$1.20
Low today
$1.04
52 Week high
$2.73
52 Week low
$0.69

Quantum-Si (QSI) at a glance

Quantum-Si (QSI) last traded at $1.16, with a market cap of 253.91M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.04 and $1.20. The current price is 11.5% above the day's low and 3.3% below its high.

Volume so far is 6.18M shares, below the average of 11.37M shares a day.

Over the past year Quantum-Si has ranged from $0.69 to $2.73, and now sits 23% of the way up that range.

Quantum-Si met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$0.11 per share against an estimate of -$0.1178.

The average analyst price target is $2.35, 102.2% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

50%of 2 analyst ratings say Buy
  • Buy50.0%
  • Hold50.0%
  • Sell0.0%
Price target · 4 analystsAvg $2.35
Low
$1.01
Now
$1.16
High
$4.20

QSI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 18.0% on average.

  1. Q3 FY24: reported -$0.18 per share against an estimate of -$0.197
  2. Q4 FY24: reported -$0.23 per share against an estimate of -$0.1885
  3. Q1 FY25: reported -$0.11 per share against an estimate of -$0.1549
  4. Q2 FY25: reported -$0.16 per share against an estimate of -$0.1414
  5. Q3 FY25: reported -$0.17 per share against an estimate of -$0.138
  6. Q4 FY25: reported -$0.08 per share against an estimate of -$0.1246
  7. Q1 FY26: reported -$0.10 per share against an estimate of -$0.1111
  8. Q2 FY26: reported -$0.11 per share against an estimate of -$0.1178

QSI news

  • Evette Mitkov

    Quantum-Si Stock Booms: What's Going On?

  • Vandana Singh

    Why Is Quantum-Si Stock Gaining Tuesday?

  • Press releaseBusiness Wire

    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Press releaseBusiness Wire

    Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™

  • Press releaseBusiness Wire

    Quantum-Si Announces the Expansion of the Proteus™ Roadshow

  • Press releaseBusiness Wire

    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Press releaseBusiness Wire

    Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones

  • Press releaseBusiness Wire

    Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ

Similar companies

Companies in the same industry as Quantum-Si

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.